Trademark applications and grants for Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals Inc has 11 trademark applications. The latest application filed is for "a symbol or image mark"
Patent Application | Date |
---|---|
CONJOINT THERAPY FOR TREATING SEIZURE DISORDERS 20220288057 - 17/668316 JOHNSON, JR.; James Philip | 2022-09-15 |
METHODS AND USES FOR TREATING ANHEDONIA 20220265634 - 17/668340 PIMSTONE; Simon Neil | 2022-08-25 |
METHODS FOR TREATING ABSENCE SEIZURES 20220193070 - 17/532909 SHERRINGTON; Robin Paul ;   et al. | 2022-06-23 |
SOLID STATE FORMS OF A SELECTIVE POTASSIUM CHANNEL MODULATOR 20220064120 - 17/368766 BICHLER; Paul Robert ;   et al. | 2022-03-03 |
METHODS FOR ENHANCING THE BIOAVAILABILITY AND EXPOSURE OF A VOLTAGE-GATED POTASSIUM CHANNEL OPENER 20220062266 - 17/449785 BEATCH; Gregory N. | 2022-03-03 |
NCAGE Code | L04U3 | XENON PHARMACEUTICALS INC |
CAGE Code | L04U3 | XENON PHARMACEUTICALS INC |
SEC | 0001582313 | Xenon Pharmaceuticals Inc. of BRITISH COLUMBIA, CANADA |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.